Aulin Sherry

Former officer at XENE

Sold, on record
$1.4M
Dollars the filings state
Form 4 sales
2
Latest Dec 18, 2024
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • XENEXenon Pharmaceuticals Inc.Former officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
2
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. 1 Form 4 sale XENEUnusual
    Sep 2, 2022 2022

    Sold 15,355 shares at $39.57 ($608k)

    Aulin Sherry, Chief Financial Officer

    Sold 100% of holdings ($608k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 144 notice XENENotice
    Dec 18, 2024 +838 days

    Filed to sell 18,709 shares ($771k)

    Aulin Sherry, Officer

    No 10b5-1 planFirst sale on recordFiling

  3. 3 Form 4 sale XENEUnusual
    Dec 18, 2024 same day

    Sold 18,709 shares at $41.21 ($771k)

    Aulin Sherry, Chief Financial Officer

    No 10b5-1 planSold 100% of holdings ($771k position)0 shares leftFirst sale on recordFollows a Form 144Filing

  4. 4 Form 144 notice XENENotice
    Sep 19, 2025 +275 days

    Filed to sell 2,548 shares ($94k)

    Aulin Sherry, Former officer

    No 10b5-1 planFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Aulin Sherry
Source
Sep 19, 2025Sep 19, 2025XENEFormer officerForm 144 notice2,548$94kNoticeSEC
Dec 18, 2024Dec 19, 2024XENEChief Financial OfficerForm 4 sale18,709$771k100.0%UnusualSEC
Dec 18, 2024Dec 18, 2024XENEOfficerForm 144 notice18,709$771kNoticeSEC
Sep 2, 2022Sep 7, 2022XENEChief Financial OfficerForm 4 sale15,355$608k100.0%UnusualSEC